A case of atypical prolonged hematologic toxicity with azacitidine in Chronic Myelomonocytic Leukemia (CMML), review of literature and a proposal of management

A case of atypical prolonged hematologic toxicity with azacitidine in Chronic Myelomonocytic Leukemia (CMML), review of literature and a proposal of management

Show other versions (1)

Hypomethylating drugs are useful and approved in the management of myelodysplastic syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML). However, phase 2 and 3 studies that assessed these agents in MDS, have included only a small number of CMML, and there are only few specific reports on CMML...

Full description

Bibliographic Details
Main Authors: Elena Elli, Caterina Cecchetti, Angelo Belotti, Lorenza Borin, Enrico Maria Pogliani
Format: Article
Language:English
Published: PAGEPress Publications 2012-03-01
Series:Mediterranean Journal of Hematology and Infectious Diseases
Subjects:
Chronic myelomonocytic leukemia
azacitidine
myelodysplastic syndromes
Hematologic toxicity
Online Access:http://www.mjhid.org/index.php/mjhid/article/view/386

Internet

http://www.mjhid.org/index.php/mjhid/article/view/386

Similar Items